KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $4.7 million.

  • Repligen's Capital Expenditures fell 3266.5% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year decrease of 3304.51%. This contributed to the annual value of $25.7 million for FY2024, which is 2911.21% down from last year.
  • Repligen's Capital Expenditures amounted to $4.7 million in Q3 2025, which was down 3266.5% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Repligen's Capital Expenditures peaked at $32.1 million during Q4 2021, and registered a low of $3.6 million during Q1 2025.
  • For the 5-year period, Repligen's Capital Expenditures averaged around $12.1 million, with its median value being $8.4 million (2023).
  • In the last 5 years, Repligen's Capital Expenditures skyrocketed by 42113.74% in 2021 and then crashed by 6872.15% in 2023.
  • Over the past 5 years, Repligen's Capital Expenditures (Quarter) stood at $32.1 million in 2021, then crashed by 36.35% to $20.4 million in 2022, then crashed by 45.77% to $11.1 million in 2023, then crashed by 50.03% to $5.5 million in 2024, then fell by 15.13% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $7.1 million for Q2 2025, and $3.6 million during Q1 2025.